电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

FBLN3 抗体 (AA 258-493)

This anti-FBLN3 antibody is a 小鼠 单克隆 antibody detecting FBLN3 in WB. Suitable for 人.
产品编号 ABIN7617400
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for FBLN3 抗体 (AA 258-493) (ABIN7617400)

抗原

See all FBLN3 抗体
FBLN3 (Fibulin 3 (FBLN3))

适用

  • 62
  • 23
  • 15
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 2
  • 2
  • 1

宿主

  • 55
  • 9
小鼠

克隆类型

  • 46
  • 18
单克隆

标记

  • 39
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This FBLN3 antibody is un-conjugated

应用范围

  • 58
  • 40
  • 22
  • 18
  • 11
  • 10
  • 10
  • 5
  • 3
  • 2
  • 1
Western Blotting (WB)

克隆位点

C7
  • 抗原表位

    • 9
    • 6
    • 5
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 258-493

    原理

    Fibulin 3 (FBLN3) Monoclonal Antibody

    序列

    Cys258~Phe493

    产品特性

    The Fibulin 3 (FBLN3) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB.

    纯化方法

    Protein A + Protein G affinity chromatography

    亚型

    IgG1 lambda
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    1 mg/mL

    缓冲液

    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol

    储存液

    ProClin

    注意事项

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C,-20 °C

    储存方法

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    有效期

    12 months
  • 抗原

    FBLN3 (Fibulin 3 (FBLN3))

    别名

    FBLN3

    基因ID

    2202

    UniProt

    Q12805

    途径

    EGFR Signaling Pathway
You are here: